Michael Wolf - Concepedia

Author

Michael Wolf

University of Zurich ORCID

Also Known As

M WOLF, M Wolf, M. Wolf, MICHAEL WOLF, Michael K. Wolf, Michael NMI Wolf, Michael Wolf, Wolf, Michael

303

Publications

28.6K

Citations

H-Index

186

Concepts

All Affiliations

University of Zurich Stanford University Universitat Pompeu Fabra Capital University Amgen (United States)

About

Michael Wolf is an author at University of Zurich specializing in statistics, statistical inference, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	22	26	5.4K
2	Business	16	17	3.8K
3	Management	8	8	2.6K
4	Health Sciences	6	6	492
5	Education	1	1	22

Michael Wolf

118

Publications

26.9K

Citations

H-Index

Page 1

	Year	Citations
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2008	3.1K
A well-conditioned estimator for large-dimensional covariance matrices Olivier Ledoit, Michael Wolf Journal of Multivariate Analysis Well-conditioned EstimatorEngineeringHigh-dimensional MethodStatistical InferenceEstimation Theory	2003	2.8K
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer Mark G. Kris, Ronald B. Natale, Roy S. Herbst, JAMA	2003	2.5K
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Eric Van Cutsem, Marc Peeters, Salvatore Siena, Journal of Clinical Oncology	2007	2K
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Jean‐Yves Douillard, Salvatore Siena, James T. Cassidy, Journal of Clinical Oncology	2010	1.8K
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Journal of Clinical Oncology	2004	1.7K
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Journal of Clinical Oncology	2004	1.7K
Improved estimation of the covariance matrix of stock returns with an application to portfolio selection Olivier Ledoit, Michael Wolf Journal of Empirical Finance Portfolio OptimizationCovariance MatrixAsset PricingPortfolio SelectionManagement	2003	1.7K
Robust performance hypothesis testing with the Sharpe ratio Olivier Ledoit, Michael Wolf Journal of Empirical Finance Robust StatisticSharpe RatioRobustness TestingRobust StatisticsStatistical Inference	2008	926
Nonlinear shrinkage estimation of large-dimensional covariance matrices Olivier Ledoit, Michael Wolf The Annals of Statistics EngineeringHigh-dimensional MethodData ScienceEstimation StatisticImproved Estimators	2012	433

Page 1